Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

NCT01289431 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Conjunctivitis, Allergic

Interventions

DRUG: Mapracorat
DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated